Ana Aslan National Institute of Gerontology and Geriatrics is the first Institute of Geriatrics and Gerontology in the world, founded by Prof Ana Aslan , MD, in 1952. The Institute treats more than 14,000 patients annually.The first drug created to delay the aging process, Gerovital H3, was developed by Ana Aslan, who initiated a complex, multidimensional approach to assess the phenomenon of human aging: the fundamental research of intimate processes at the cellular and sub-cellular levels involved in transformations that accompany aging; assessing changes in the human body over the years; the implications of the aging phenomenon at the level of large human collectives - social gerontology. We are using Gerovital H3 in our Aslan therapy method, with amazing results for our patients all over the world.